Abbott Laboratories recalls Alinity ci-series System Control Module (SCM)
Reason for recall
Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.
Affected product
Check your device
Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.
Affected products & lots
- Alinity ci-series System Control Module (SCM), REF: 03R70-0103R70-20UDI-DI 00380740137410.GTIN 06952999490048.400 affected lotsSCM01010SCM01012SCM01016SCM01035SCM01043SCM01051SCM01063SCM01069
+392 more
SCM01075SCM01076SCM01078SCM01082SCM01085SCM01086SCM01087SCM01088SCM01092SCM01093SCM01094SCM01095SCM01098SCM01099SCM01101SCM01102SCM01106SCM01107SCM01110SCM01115SCM01116SCM01120SCM01121SCM01122SCM01123SCM01124SCM01126SCM01127SCM01128SCM01129SCM01132SCM01134SCM01135SCM01136SCM01137SCM01138SCM01142SCM01143SCM01149SCM01150SCM01151SCM01154SCM01163SCM01166SCM01170SCM01171SCM01172SCM01174SCM01175SCM01176SCM01179SCM01180SCM01181SCM01184SCM01192SCM01193SCM01194SCM01196SCM01197SCM01198SCM01199SCM01200SCM01201SCM01203SCM01204SCM01205SCM01207SCM01211SCM01213SCM01216SCM01217SCM01219SCM01220SCM01221SCM01222SCM01223SCM01224SCM01225SCM01226SCM01229SCM01230SCM01232SCM01236SCM01237SCM01238SCM01239SCM01240SCM01244SCM01247SCM01249SCM01251SCM01252SCM01253SCM01254SCM01255SCM01256SCM01257SCM01258SCM01267SCM01268SCM01269SCM01270SCM01271SCM01273SCM01274SCM01277SCM01279SCM01281SCM01282SCM01283SCM01284SCM01286SCM01289SCM01290SCM01291SCM01293SCM01294SCM01297SCM01298SCM01300SCM01301SCM01302SCM01305SCM01306SCM01307SCM01308SCM01310SCM01312SCM01313SCM01314SCM01315SCM01316SCM01317SCM01320SCM01321SCM01323SCM01326SCM01328SCM01333SCM01334SCM01335SCM01336SCM01337SCM01338SCM01339SCM01340SCM01341SCM01342SCM01343SCM01344SCM01345SCM01346SCM01348SCM01349SCM01350SCM01354SCM01355SCM01356SCM01357SCM01361SCM01362SCM01365SCM01368SCM01370SCM01371SCM01372SCM01373SCM01374SCM01375SCM01376SCM01377SCM01378SCM01379SCM01380SCM01381SCM01382SCM01383SCM01385SCM01386SCM01387SCM01388SCM01389SCM01393SCM01394SCM01395SCM01396SCM01397SCM01399SCM01401SCM01402SCM01403SCM01404SCM01405SCM01406SCM01407SCM01408SCM01409SCM01411SCM01412SCM01414SCM01415SCM01416SCM01417SCM01418SCM01421SCM01422SCM01423SCM01424SCM01425SCM01429SCM01430SCM01431SCM01432SCM01433SCM01434SCM01437SCM01438SCM01439SCM01440SCM01442SCM01443SCM01444SCM01445SCM01446SCM01447SCM01448SCM01449SCM01450SCM01451SCM01452SCM01453SCM01454SCM01455SCM01456SCM01457SCM01458SCM01460SCM01461SCM01462SCM01465SCM01466SCM01467SCM01468SCM01469SCM01470SCM01471SCM01473SCM01474SCM01475SCM01476SCM01478SCM01479SCM01480SCM01481SCM01483SCM01485SCM01486SCM01487SCM01489SCM01491SCM01492SCM01493SCM01494SCM01495SCM01496SCM01497SCM01499SCM01501SCM01503SCM01504SCM01505SCM01506SCM01508SCM01511SCM01512SCM01513SCM01515SCM01517SCM01518SCM01519SCM01524SCM01525SCM01526SCM01527SCM01528SCM01529SCM01530SCM01531SCM01532SCM01534SCM01535SCM01536SCM01539SCM01540SCM01542SCM01544SCM01545SCM01547SCM01548SCM01553SCM01556SCM01557SCM01558SCM01560SCM01561SCM01562SCM01563SCM01564SCM01566SCM01567SCM01568SCM01569SCM01570SCM01571SCM01572SCM01575SCM01576SCM01577SCM01579SCM01580SCM01581SCM01582SCM01584SCM01586SCM01587SCM01588SCM01589SCM01593SCM01594SCM01595SCM01597SCM01598SCM01599SCM01600SCM01601SCM01602SCM01603SCM01604SCM01605SCM01607SCM01608SCM01609SCM01610SCM01611SCM01613SCM01615SCM01616SCM01617SCM01618SCM01619SCM01620SCM01622SCM01623SCM01624SCM01625SCM01627SCM01630SCM01631SCM01632SCM01633SCM01634SCM01635SCM01636SCM01638SCM01641SCM01642SCM01645SCM01647SCM01648SCM01649SCM01650SCM01651SCM01652SCM01654SCM01655SCM01657SCM01659SCM01660SCM01661SCM01662SCM01665SCM01666SCM01668SCM01669SCM01670SCM01678SCM01680SCM01681SCM01682SCM01683SCM01684SCM01686
What the firm is doing
On 11/13/2025, "Urgent Field Safety Notice Product Correction" notices were sent to customers who were asked to take the following actions: 1) Perform the Weekly maintenance procedures (i-series) 2630 Manual Wash Cup Cleaning (i-series) per Section 9 of the Alinity ci-series Operations Manual. 2) Field Service Representative will contact you to schedule installation of software version 3.7.0. 3) It is recommended to perform the Pipettor diagnostic procedures (c-series) 4109 Probe Alignment Test (c-series) daily for R1 and R2 pipettor probes per Section 9 of the Alinity ci-series Operations Manual until software version 3.7.0 is installed. 4) If you observe a bent pipettor probe (R1, R2), perform the component replacement procedure, Replace the reagent probes (c-series) per Section 9 of the Alinity ci-series Operations Manual. If you have forwarded the product to other laboratories, please inform them of this product correction and provide to them a copy of this letter. If you have questions regarding this information, contact Customer Service at 1-877-4ABBOTT.
DistributionShow detailsHide
Worldwide distribution: US (nationwide) to states of: AK, AL, AR, AZ, CA, CO, CT, DE, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NH, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, PR; and OUS (foreign) to countries of: Albania, Algeria, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Cambodia, Cameroon, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Faroe Islands, Finland, France, Gaza & Jericho, Georgia, Germany, Greece, Greenland, Guatemala, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Kazakhstan, Kenya, Kosovo, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Lithuania, Macedonia, Malawi, Malaysia, Maldives, Malta, Mauritania, Mauritius, Mexico, Moldova, Montenegro, Morocco, Namibia, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Northern Ireland, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia (CIS), Rwanda, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad & Tobago, Tunisia, Turkey, UAE, Uganda, Ukraine, United Kingdom, Uruguay, Vietnam and Zambia. OUS: ALBANIA, ALGERIA, ANDORRA, ARGENTINA, AUSTRALIA, AUSTRIA, AZERBAIJAN, BAHAMAS, BAHRAIN, BANGLADESH, BELARUS, BELGIUM, BOSNIA AND HERZEGOVINA, BOTSWANA, BRAZIL, BRUNEI, BULGARIA, CAMBODIA, CAMEROON, CANADA, CAYMAN ISLANDS, CHILE, CHINA, COLOMBIA, COSTA RICA, CROATIA, CYPRUS, CZECH REPUBLIC, DENMARK, ECUADOR, EGYPT, EL SALVADOR, ESTONIA, ETHIOPIA, FAROE ISLANDS, FINLAND, FRANCE, GAZA & JERICHO, GEORGIA, GERMANY, GREECE, GREENLAND, GUATEMALA, HONDURAS, HONG KONG, HUNGARY, INDIA, INDONESIA, IRAN, IRAQ, IRELAND, ISRAEL, ITALY, JAMAICA, JAPAN, JORDAN, KAZAKHSTAN, KENYA, KOSOVO, KUWAIT, KYRGYZSTAN, LATVIA, LEBANON, LIBYA, LITHUANIA, MACEDONIA, MALAWI, MALAYSIA, MALDIVES, MALTA, MAURITANIA, MAURITIUS, MEXICO, MOLDOVA, MONTENEGRO, MOROCCO, NAMIBIA, NEPAL, NETHERLANDS, NEW CALEDONIA, NEW ZEALAND, NICARAGUA, NORTHERN IRELAND, NORWAY, OMAN, PAKISTAN, PANAMA, PARAGUAY, PERU, PHILIPPINES, POLAND, PORTUGAL, QATAR, ROMANIA, RUSSIA (CIS), RWANDA, SAUDI ARABIA, SENEGAL, SERBIA, SINGAPORE, SLOVAKIA, SLOVENIA, SOUTH AFRICA, SOUTH KOREA, SPAIN, SWEDEN, SWITZERLAND, TAIWAN, THAILAND, TRINIDAD & TOBAGO, TUNISIA, TURKEY, UAE, UGANDA, UKRAINE, UNITED KINGDOM, URUGUAY, VIETNAM, ZAMBIA
Use of the product may cause temporary or medically reversible adverse health consequences.
Sources & references
- FDA enforcement recordOfficial FDA database entry for Z-0961-2026
- FDA 510(k) clearance · K170316The device's official FDA premarket clearance record
- FDA 510(k) clearance · K170317The device's official FDA premarket clearance record
- FDA device classification · JJEOfficial FDA classification for this device type
- CFR regulation · 21 CFR 862.2160The federal regulation governing this device
- FDA recall announcementSearch FDA.gov for the official press announcement
- Find Abbott LaboratoriesSearch for the manufacturer's official notice
- News coverageRecent reporting on this recall and manufacturer
- openFDA data recordThe raw JSON record this page is built from
Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.
Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.
More Class II recalls
Cardinal Health 200, LLC recalls Cardinal Health Presource Kits: 1) BASIC PACK
Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.
- Eye Tray
- Nonconforming Material/Component
Cardinal Health 200, LLC recalls Cardinal Health Presource Kits: 1) KIT
Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.
- Orthopedic Tray
- Nonconforming Material/Component
Cardinal Health 200, LLC recalls Cardinal Health Presource Kits: 1) CHI STD NEURO CRANI OPT 2
Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.
- Neurological Tray
- Nonconforming Material/Component
